Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cheng Xin Technology Development Corp

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 2
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Medical
  • Therapeutics
  • Genetics
  • Biotechnology
  • Biopharma
Summary

The venture was found in Asia in Taiwan. The leading representative office of defined VC is situated in the Taipei.

Among the various public portfolio startups of the fund, we may underline AGY Therapeutics, AGY Therapeutics Among the most successful fund investment fields, there are Genetics, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The usual cause for the fund is to invest in rounds with 8 partakers. Despite the Cheng Xin Technology Development Corp, startups are often financed by Novartis Venture Fund, Alta Partners, Lombard Odier. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Lotus, JAFCO Japan. In the next rounds fund is usually obtained by Novartis Venture Fund, Lotus, Life Sciences Partners.

Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2004.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cheng Xin Technology Development Corp:
Typical Co-investors
Cheng Xin Technology Development Corp is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cheng Xin Technology Development Corp:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Antin Infrastructure Partners France, Ile-de-France, Paris
Avila Venture Capital -
Blue Slide Ventures New York, New York, United States
British Business Investments England, Sheffield, United Kingdom
Carolina Power & Light -
Cox Orange Investment Ltd Canada, Lions Head, Ontario
Cygnus Equity China, Shanghai
DEFT Alabama, Birmingham, United States
Endeavor Equity Holdings -
Innalabs Holding Dulles, United States, Virginia
Lifetime Ventures Japan, Tokyo
MGG Investment Group New York, New York, United States
Narbona Hill Corp. California, San Francisco, United States
Omicron Media Florida, United States, Winter Park
Patria Mobile -
Renhe Capital China, Guangdong, Shenzhen
Sinvo Group Beijing, China, Haidian
Youmi.net China, Guangdong, Panyu

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AGY Therapeutics

Biopharma
Biotechnology
Genetics
Medical
Therapeutics
$9M07 Aug 2004 San Francisco, California, United States

NewBiotics

Health Care
Medical
Therapeutics
$11M25 Jul 2001 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cheng Xin Technology Development Corp?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 10M
Peak activity year 2004
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AGY Therapeutics

Biopharma
Biotechnology
Genetics
Medical
Therapeutics
$9M07 Aug 2004 San Francisco, California, United States

NewBiotics

Health Care
Medical
Therapeutics
$11M25 Jul 2001 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: